{"id":"NCT02387294","sponsor":"Fluart Innovative Vaccine Ltd, Hungary","briefTitle":"Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection for Children and Adolescents","officialTitle":"Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (Trivalent, Seasonal Influenza Vaccine, Active Ingredient Content: 6 μg HA/Strain/0.5 ml) for Children and Adolescents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-10","primaryCompletion":"2014-12","completion":"2014-12","firstPosted":"2015-03-13","resultsPosted":"2021-03-11","lastUpdate":"2021-03-11"},"enrollment":120,"design":{"allocation":"NON_RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Human Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"Vaccination with Fluval AB Novo suspension for injection, half dose of a single intramuscular dose (0.25 ml)","otherNames":["Fluval AB Novo suspension for injection"]},{"type":"BIOLOGICAL","name":"Vaccination with Fluval AB Novo suspension for injection, single intramuscular dose (0.5 ml)","otherNames":[]}],"arms":[{"label":"Age group 1: children (3-11 years)","type":"EXPERIMENTAL"},{"label":"Age group 2: adolescents (12-18 years)","type":"EXPERIMENTAL"}],"summary":"Immunogenicity and Tolerability Study of Fluval AB Novo Suspension for Injection (trivalent, seasonal influenza vaccine, active ingredient content: 6 μg HA/strain/0.5 ml) for Children and Adolescents.","primaryOutcome":{"measure":"Increase in Geometric Mean Titre Ratio, A/H1N1 Strain","timeFrame":"21-28 days after vaccination","effectByArm":[{"arm":"Age Group 1: Children (3-11 Years)","deltaMin":4.337,"sd":null},{"arm":"Age Group 2: Adolescents","deltaMin":4.702,"sd":null}],"pValues":[]},"eligibility":{"minAge":"3 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":6,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":60},"commonTop":["vaccination site pain","myalgia","vaccination site erythema","vaccination site swelling","malaise"]}}